medigraphic.com
SPANISH

Hipócrates Revista Médica

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2010, Number 23

<< Back Next >>

Hipoc Rev Med 2010; 5 (23)

Neurocisticercosis en México, revisión de la literatura

Valenzuela-Borrayo LC
Full text How to cite this article

Language: Spanish
References: 12
Page: 4-8
PDF size: 69.74 Kb.


Key words:

No keywords

ABSTRACT

No abstract


REFERENCES

  1. Ansari JA1, Karki P1, Dwivedi S1, Ghotekar LH1, Rauniyar RK2, Rijal S1 1Dept. of Medicine, 2Department of Radiology, B P KoiralaInstitute of HealthSciences, Dharan Nepal. Neurocysticercosis-a review. KathmanduUniversity Medical Journal 2003, Vol. 1, No. 1, 48-55.

  2. Fleury A, Moreno Garcı´a J, Valdez Aguerrebere P, de SayveDura´n M, Becerril Rodrı´guez P, et al. (2010) Neurocysticercosis, a Persisting Health Problem inMexico. PLoSNegl Trop Dis 4(8): e805. doi:10.1371/journal.pntd.0000805, August 2010.

  3. Ndimubanzi PC, Carabin H, Budke CM, Nguyen H, Qian Y-J, et al. (2010) A Systematic Review of the Frequency of Neurocyticercosis with a Focus onPeople with Epilepsy. PLoSNegl Trop Dis 4(11): e870. doi:10.1371/journal.pntd.0000870, November 2, 2010.

  4. Julio Sotelo, Oscar H del Brutto, M.D.. Review of neurocysticercosis. Neurosurg. Focus / Volume 12 / June, 2002.

  5. De Giorgio C M.D, Medina Marco T, M.D, Duron, Reyna M.D, Chi Zee, M.D, SusanPietschEcueta, M.P.H. Neurocysticercosis current review. Vol.4, No.3 (May/June)2004 pp. 107-111. Blackwell Publishing, Inc.

  6. Hector H. García,1,2* Carlton A. W. Evans,3,4 Theodore E. Nash,5 Osvaldo M. Takayanagui CurrentConsensusGuidelinesfor- Treatment of Neurocysticercosis. Clinical Microbilogical Review, Oct. 2002, p. 747–756 Vol. 15, No.4.

  7. Eric T. Kimura-Hayama, MD • Jesús A. Higuera, MD • Roberto Corona- Cedillo, MD • Laura Chávez-Macías, MD • AnamariPerochena, MD Laura Yadira Quiroz-Rojas, MD • Jesús Rodríguez-Carbajal, MD • José L. Criales, MD, Neurocysticercosis: Radiologic-PathologicCorrelation.

  8. Jorge Burneo G, MD, MSPH,NEUROCYSTICERCOSIS. Oct 2, 2006.

  9. O.R. Del Brutto, MD, V. Rajshekhar, MCh, A.C. White Jr, MD, the Infectious Disease Section (Dr. White), Department of Medicine, Baylor College of Medicine, Houston, Neurology. 2001 July 24; 57(2): 177–183.

  10. Garcia H, Del Brutto O, New concepts in the diagnosis and management of neurocysticercosis. Am. J. Trop. Med. Hyg., 72(1), 2005, pp. 3–9 2005 byThe American Society of Tropical Medicine and Hygiene.

  11. Matthaiou DK, Panos G, Adamidi ES, Falagas ME (2008) Albendazole versus Praziquantel in the Treatment of Neurocysticercosis: A Meta-analysis ofComparative Trials. PLoSNegl Trop Dis 2(3): e194. doi:10.1371/journal.pntd.0000194, March 12, 2008.

  12. Abba K, Ramaratnam S, Ranganathan LN. Anthelmintics for people with neurocysticercosis. Cochrane Database of Systematic Reviews 2010.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Hipoc Rev Med. 2010;5